{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:21:30Z","timestamp":1740165690726,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Canc Conf J"],"DOI":"10.1007\/s13691-023-00622-w","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T05:01:56Z","timestamp":1690347716000},"page":"279-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report"],"prefix":"10.1007","volume":"12","author":[{"given":"Shinichiro","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-5861","authenticated-orcid":false,"given":"Qingjiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Natsugoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Harima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Nambara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Nakanoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasue","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"1","key":"622_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40792-019-0712-8","volume":"5","author":"S Yasuda","year":"2019","unstructured":"Yasuda S, Harada S, Tsujimoto A et al (2019) A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report. Surg case Rep 5(1):146","journal-title":"Surg case Rep"},{"issue":"8","key":"622_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s10147-020-01703-z","volume":"25","author":"Y Nishikawa","year":"2020","unstructured":"Nishikawa Y, Hoshino N, Horimatsu T et al (2020) Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review. Int J Clin Oncol 25(8):1441\u20131449","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"622_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/jjco\/hyy086","volume":"48","author":"T Hirashita","year":"2018","unstructured":"Hirashita T, Ohta M, Tada K et al (2018) Prognostic factors of non-ampullary duodenal adenocarcinoma. Jpn J Clin Oncol 48(8):743\u2013747","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"622_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"L Alicia","year":"2019","unstructured":"Alicia L, Preethi S, Yelena K et al (2019) Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. J Clin Oncol 37(4):286\u2013295","journal-title":"J Clin Oncol"},{"issue":"3","key":"622_CR5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/cas.14798","volume":"112","author":"K Akagi","year":"2021","unstructured":"Akagi K, Oki E, Taniguchi H et al (2021) Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci 112(3):1105\u20131113","journal-title":"Cancer Sci"},{"issue":"9","key":"622_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","volume":"33","author":"M Maio","year":"2022","unstructured":"Maio M, Ascierto PA, Mnzyuk L et al (2022) Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: update analysis from the phase II KEYNOTE-158 study. Ann Oncol 33(9):929\u2013938","journal-title":"Ann Oncol"},{"issue":"5","key":"622_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdu100","volume":"25","author":"J Goldstein","year":"2014","unstructured":"Goldstein J, Tran B, Ensor J et al (2014) Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol 25(5):1032\u20131038","journal-title":"Ann Oncol"},{"issue":"1","key":"622_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"M Aurelien","year":"2020","unstructured":"Aurelien M, Dung T, Paolo AA et al (2020) Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol 38(1):1\u201310","journal-title":"J Clin Oncol"},{"issue":"9","key":"622_CR9","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1245\/s10434-018-6567-6","volume":"25","author":"LM Laura","year":"2018","unstructured":"Laura LM, Anna JA, Jacov KB et al (2018) Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol 25(9):2681\u20132692","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"622_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semradonc.2013.11.001","volume":"24","author":"SK Jabbour","year":"2014","unstructured":"Jabbour SK, Mulvihill D (2014) Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol 24(2):85\u201393","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"622_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9610(99)00269-X","volume":"179","author":"IG Kaklamanos","year":"2000","unstructured":"Kaklamanos IG, Bathe OF, Franceschi D et al (2000) Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 179(1):37\u201341","journal-title":"Am J Surg"},{"issue":"2","key":"622_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11605-011-1667-7","volume":"16","author":"OO Edwin","year":"2012","unstructured":"Edwin OO, Sarah YB, Michael GS et al (2012) Neoadjuvant Treatment of Duodenal Adenocarcinoma: A Rescue Strategy. J Gastrointest Surg 16(2):320\u2013324","journal-title":"J Gastrointest Surg"},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/CEG.S278054","volume":"14","author":"T Christina","year":"2021","unstructured":"Christina T, Lars HJ, Maria R et al (2021) An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome. Clin Exp Gastroenterol 14:181\u2013197","journal-title":"Clin Exp Gastroenterol"},{"issue":"9","key":"622_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(08)70232-8","volume":"9","author":"JK Jan","year":"2008","unstructured":"Jan JK, Jan HK, Hans FA (2008) Small-bowel cancer in Lynch syndrome: is it time for surveillance? Lancet Oncol 9(9):901\u2013905","journal-title":"Lancet Oncol"},{"issue":"2","key":"622_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.dld.2018.10.005","volume":"51","author":"H Nassim","year":"2019","unstructured":"Nassim H, Marion D, Stanislas C et al (2019) Duodenal tumor risk in Lynch syndrome. Dig Liver Dis 51(2):299\u2013303","journal-title":"Dig Liver Dis"},{"issue":"4","key":"622_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10689-009-9280-6","volume":"8","author":"H Naruse","year":"2009","unstructured":"Naruse H, Ikawa N, Yamaguchi K et al (2009) Determination of splice-site mutation in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Fam Cancer 8(4):509\u2013517","journal-title":"Fam Cancer"},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509\u20132520","journal-title":"N Engl J Med"},{"issue":"12","key":"622_CR18","doi-asserted-by":"publisher","first-page":"e2110","DOI":"10.1002\/onco.13955","volume":"26","author":"T Jorg","year":"2021","unstructured":"Jorg T, Sebastian S, Oliver H et al (2021) Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H\/dMMR Rectal Cancer. Oncologist 26(12):e2110\u2013e2114","journal-title":"Oncologist"}],"container-title":["International Cancer Conference Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13691-023-00622-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13691-023-00622-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13691-023-00622-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T03:38:31Z","timestamp":1691811511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13691-023-00622-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1007\/s13691-023-00622-w","relation":{},"ISSN":["2192-3183"],"issn-type":[{"type":"electronic","value":"2192-3183"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that this study conformed with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all human participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}